| Bioactivity | IRE1α kinase-IN-8, a benzoheterocyclecarboxaldehyde derivative, is a potent IRE-1α inhibitor. IRE1α kinase-IN-8 can be used for research in diseases associated with the unfolded protein response or with regulated IRE1-dependent decay (RIDD)[1]. |
| Target | IRE-1α |
| Name | IRE1α kinase-IN-8 |
| CAS | 1338933-29-1 |
| Formula | C23H22N2O5 |
| Molar Mass | 406.43 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zeng QP, et al. Benzoheterocyclecarboxaldehyde derivatives as IRE-1α inhibitors and their preparation and use for the treatment of diseases. World Intellectual Property Organization, WO2011127070 A2. 2011-10-13. |
IRE1α kinase-IN-8
CAS: 1338933-29-1 F: C23H22N2O5 W: 406.43
IRE1α kinase-IN-8, a benzoheterocyclecarboxaldehyde derivative, is a potent IRE-1α inhibitor. IRE1α kinase-IN-8 can b
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.